4.17, 2007
UMN Pharma makes presentation at the annual meeting of the American Association for Cancer Research (AACR) held in Los Angeles, California in 2007.
Researchers at UMN Pharma Inc. presented results
from a microarray analysis of tumor tissue after
the administration of UMN-01. In this study, mice
bearing MKN74, stomach cancer cells, were administered
UMN-01 and were subsequently studied using cDNA
microarrayanalysis. Researchers found that intravenous
injection of UMN-01 significantly suppressed tumor
growth in this model. In addition, some probes or
genes demonstrated interesting changes in their
signature patterns with respect to the anti-tumor
effect seen in the cDNA microarray analysis. Further
details about our presentation can be found in the
conference proceedings from the American Association
of Cancer Research (AACR).






